C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer
- PMID: 25698539
- DOI: 10.1007/s12032-015-0547-5
C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer
Abstract
In our previous study, the epithelial-to-mesenchymal transition (EMT) has been identified to be involved in gastric cancer progression. Notably, nuclear protein C23 and bone morphogenetic protein-2 (BMP2) have been linked into EMT. However, the specific mechanisms underlying BMP2 pathway-mediated EMT are not still unraveled. In this study, we adopted immunohistochemistry and immunoblotting to determine the expression of C23 and BMP2 receptor II (BMPR-II) in 90 gastric cancer samples and cell lines. Subsequently, relevant cell lines were selected to be treated with si-C23 or si-BMPRII and the detection of in vitro assay. Our results revealed that both C23 and BMPRII were aberrantly and constitutively expressed in gastric cancer specimens and cell lines, whose expression was positively associated with metastasis, stage and differentiation, and portended poor survival outcome of gastric cancer patients. In vitro assay validated the increased expression of p-Erk1/2, p-Akt, vimentin, N-cadherin, and MMP2 in BMP2-stimulated MGC803 cells, which was in a dose-dependent manner. By contrast, si-C23 treatment attenuated the BMP2-stimulated expression of p-Erk1/2, p-Akt, vimentin, N-cadherin, and MMP2. Also, the treatment of either si-C23 or si-BMPRII decreased the ability of migration and invasion of MGC803 cells. In conclusion, C23 mediates BMP2-induced EMT progression via the up-regulation of Erk1/2 and Akt signaling pathway in gastric cancer, which indicated both C23 and BMPRII pathway could be recommended as prospective targets or biomarkers to antagonize the progression of gastric cancer.
Similar articles
-
CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.Cytokine. 2015 Dec;76(2):163-169. doi: 10.1016/j.cyto.2015.05.009. Epub 2015 Jun 1. Cytokine. 2015. PMID: 26044596
-
Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer.Tumour Biol. 2015 Apr;36(4):2773-8. doi: 10.1007/s13277-014-2901-1. Epub 2014 Dec 3. Tumour Biol. 2015. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 25448881 Retracted.
-
BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.Exp Cell Res. 2010 Jan 1;316(1):24-37. doi: 10.1016/j.yexcr.2009.10.010. Epub 2009 Oct 14. Exp Cell Res. 2010. PMID: 19835871
-
BMP2 as a promising anticancer approach: functions and molecular mechanisms.Invest New Drugs. 2022 Dec;40(6):1322-1332. doi: 10.1007/s10637-022-01298-4. Epub 2022 Aug 30. Invest New Drugs. 2022. PMID: 36040572 Review.
-
Mechanisms of Bone Morphogenetic Protein 2 in Respiratory Diseases.Curr Allergy Asthma Rep. 2024 Oct 28;25(1):1. doi: 10.1007/s11882-024-01181-7. Curr Allergy Asthma Rep. 2024. PMID: 39466470 Review.
Cited by
-
Epithelial-mesenchymal transition in gastric cancer.Am J Transl Res. 2015 Nov 15;7(11):2141-58. eCollection 2015. Am J Transl Res. 2015. PMID: 26807164 Free PMC article. Review.
-
Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.Tumour Biol. 2016 Sep;37(9):11723-11732. doi: 10.1007/s13277-016-5020-3. Epub 2016 Mar 28. Tumour Biol. 2016. PMID: 27020591
-
The effect of pulsed electromagnetic field exposure on osteoinduction of human mesenchymal stem cells cultured on nano-TiO2 surfaces.PLoS One. 2018 Jun 14;13(6):e0199046. doi: 10.1371/journal.pone.0199046. eCollection 2018. PLoS One. 2018. PMID: 29902240 Free PMC article.
-
Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis.Pharmaceuticals (Basel). 2021 Jan 13;14(1):60. doi: 10.3390/ph14010060. Pharmaceuticals (Basel). 2021. PMID: 33451077 Free PMC article. Review.
-
The Dual Role of Bone Morphogenetic Proteins in Cancer.Mol Ther Oncolytics. 2017 Oct 24;8:1-13. doi: 10.1016/j.omto.2017.10.002. eCollection 2018 Mar 30. Mol Ther Oncolytics. 2017. PMID: 29234727 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous